Vor Biopharma Inc (VOR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Robert Ang
Employees:
76
215 FIRST STREET, SUITE 430, CAMBRIDGE, MA 02142
617-655-6580

The mission of Vor Biopharma is to develop transformative treatments for patients suffering from hematological malignancies. We seek to accomplish our mission through our unique approach of engineering patients to better fight their cancer by unlocking the potential of targeted therapies with curative intent. We are a cell therapy company combining a novel patient engineering approach with targeted therapies to provide a single company solution for patients suffering from hematological malignancies.

Data derived from most recent annual or quarterly report
Market Cap 619.571 Million Shares Outstanding37.145 Million Avg 30-day Volume 88.895 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 63.62 / 11.78 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

View recent insider trading info

Vor Biopharma Inc YCharts
Yahoo! Finance finviz

Funds Holding VOR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VOR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CHAKRABORTY TIRTHA CHIEF SCIENTIFIC OFFICER

  • Officer
 49,780 2021-08-17 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
 11,120,973 2021-04-01 1

5AM VENTURES VI, L.P.

5AM PARTNERS VI, LLC

5AM OPPORTUNITIES I, L.P.

5AM OPPORTUNITIES I (GP), LLC

SCHWAB ANDREW J.

  • 10% Owner
 6,692,429 2021-02-09 1

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
 No longer subject to file 2021-02-09 1

JORGENSEN NATHAN D. CHIEF FINANCIAL OFFICER

  • Officer
 29,269 2021-02-09 1

PATTERSON MATTHEW R

  • Director
 0 2021-02-05 1

BECKMAN DANIELLA

  • Director
 0 2021-02-05 1

LUBNER DAVID CHARLES

  • Director
 0 2021-02-05 1

PARMAR KUSH

  • Director
  • 10% Owner
 6,692,429 2021-02-05 1

LUNDBERG SVEN ANTE

  • Director
 0 2021-02-05 1

RESNICK JOSHUA

  • Director
 0 2021-02-05 1

ANG ROBERT PRESIDENT AND CEO

  • Officer
  • Director
 0 2021-02-05 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VOR BIOPHARMA INC VOR 2021-10-25 22:15:03 UTC -1.7326 1.8026 20000
VOR BIOPHARMA INC VOR 2021-10-25 21:45:03 UTC -1.7326 1.8026 20000
VOR BIOPHARMA INC VOR 2021-10-25 21:15:03 UTC -1.7326 1.8026 20000
VOR BIOPHARMA INC VOR 2021-10-25 20:45:03 UTC -1.7326 1.8026 20000
VOR BIOPHARMA INC VOR 2021-10-25 20:15:03 UTC -1.7326 1.8026 20000
VOR BIOPHARMA INC VOR 2021-10-25 19:45:04 UTC -1.7326 1.8026 20000
VOR BIOPHARMA INC VOR 2021-10-25 19:15:03 UTC -1.7326 1.8026 20000
VOR BIOPHARMA INC VOR 2021-10-25 18:45:02 UTC -1.7514 1.8214 20000
VOR BIOPHARMA INC VOR 2021-10-25 18:15:03 UTC -1.7514 1.8214 20000
VOR BIOPHARMA INC VOR 2021-10-25 17:45:03 UTC -1.7514 1.8214 20000
VOR BIOPHARMA INC VOR 2021-10-25 17:15:03 UTC -1.7514 1.8214 20000
VOR BIOPHARMA INC VOR 2021-10-25 16:45:02 UTC -1.7543 1.8243 20000
VOR BIOPHARMA INC VOR 2021-10-25 16:15:03 UTC -1.7543 1.8243 20000
VOR BIOPHARMA INC VOR 2021-10-25 15:45:03 UTC -1.7543 1.8243 20000
VOR BIOPHARMA INC VOR 2021-10-25 15:15:03 UTC -1.7543 1.8243 20000
VOR BIOPHARMA INC VOR 2021-10-25 14:45:02 UTC -1.6684 1.7384 25000
VOR BIOPHARMA INC VOR 2021-10-25 14:15:03 UTC -1.6684 1.7384 25000
VOR BIOPHARMA INC VOR 2021-10-25 13:45:03 UTC -1.6684 1.7384 25000
VOR BIOPHARMA INC VOR 2021-10-25 13:15:03 UTC -1.6684 1.7384 25000
VOR BIOPHARMA INC VOR 2021-10-25 12:45:04 UTC -1.6684 1.7384 25000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VOR -100.0 shares, $-1865.0 2021-06-30 N-PORT

Elevate your investments